GLP-1 Disruption

GLP-1 medications are poised to revolutionize the weight loss industry, addressing America's obesity crisis, which costs the economy an astounding $1.7 trillion. As access to these treatments expands, fast food giants may face significant challenges. Meanwhile, India emerges as a new economic powerhouse, shifting production from China and attracting foreign investment while the latter grapples with internal issues and a struggling economy.